Transforming growth factor B1 Induces apoptosis by suppressing flice-like inhibitory protection in D U145 prostate epithelial cells

International Journal of Cancer

Volumn 124, Issue 4, 2009, Pages 834-842

  Yoo, Kiwen S ^a   Nastiuk, Kent L ^a   Krolewski, John J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Androgen; Caspase; FLIP; Growth factors; TGF l

Indexed keywords

CASPASE 8; FLICE INHIBITORY PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1; CASP8 PROTEIN, HUMAN; CASPASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL DEATH; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; CELL PROLIFERATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; METABOLISM; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; CASPASE 8; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 58149469246     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24024     Document Type: Article

References (50)

1. Danielpour D. Functions and regulation of transforming growth factor-β (TGF-β) in the prostate. Eur J Cancer 2005 ;41:846-57.
2. Desai KV, Kondaiah P. Androgen ablation results in differential regulation of transforming growth factor-β isoforms in rat male accessory sex organs and epididymis. J Mol Endocrinol 2000;24:253-60.
3. Kyprianou N, Isaacs JT. Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 1989;3:1515-22.
4. Kyprianou N, Isaacs J. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988;122:552-62.
5. Kim IY, Ahn HJ, Zelner DJ, Park L, Sensibar JA, Lee C. Expression and localization of transforming growth factor-β receptors type T and tvpe II in the rat ventral prostate during regression. Mol Endocrinol 1996;10:107-15.
6. Brodin G, ten Dijke P, Funa K, Heldin CH, Landstrom M. Increased sraad expression and activation are associated with apoptosis in normal and malignant prostate after castration. Cancer Res 1999;59: 2731-8.
7. Kundu SD, Kim IY, Yang T, Doglio L, Lang S, Zhang X, Butty an R, Kim SJ, Chang J, Cai X, Wang Z, Lee C. Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3( 1 )-TGF-β tvpe II dominant negative receptor. Prostate 2000;43: 118-24.
8. Tang B, de Castro K, Barnes HE, Parks WT, Stewart L, Bottinger EP, Danielpour D, Wakefield LM. Loss of responsiveness to transforming growth factor β induces malignant transformation of nontumorigenic rat prostate epithelial cells. Cancer Res 1999;59:4834-42.
9. Martikainen P, Kyprianou N, Isaacs JT. Effect of transforming growth factor-β 1 on proliferation and death of rat prostatic cells. Endocrinology 1990;127:2963-8.
10. Massague J, Gomis RR. The logic of TGFβ signaling. FEES Lett 2006;580:2811-20.
11. Pardali K, Moustakas A. Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer. Biochira Biophys Acta 2007;1775:21-62.
12. Coyle B, Freathy C, Gant TW, Roberts RA, Cain K. Characterization of the transforming growth factor-B 1-induced apoptotic tr an scrip-tome in FaO hepatoma cells. J Biol Chem 2003;278:5920-8.
13. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer 2003:3:807-21.
14. Inman GJ, Allday MJ. Apoptosis induced by TGF-β 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent. J Immunol 2000;165:2500-10.
15. Kim SG, Jong HS, Kim TY, Lee JW, Kim NK, Hong SH, Bang YJ. Transforming growth factor-β 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathwav in human gastric SNU-620 carcinoma cells. Mol Biol Cell 2004; 15:420-34.
16. Kim IY, Aim HJ, Lang S, Oefelein MG, Oyasu R, Kozlowski JM, Lee C. Loss of expression of transforming growth factor-β receptors is associated with poor prognosis in prostate cancer patients. Clin Cancer Res 1998;4:1625-30.
17. Wikstrom P, Stattin P, Franck-Lissbrant 1, Daraber JE, Bergh A. Transforming growth factor pi is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate 1998;37:19-29.
18. Zeng L, Rowland RG, Lele SM, Kyprianou N. Apoptosis incidence and protein expression of p53, TGF-β receptor II, p27Kipl, and Smad4 in benign, premalignant, and malignant human prostate. Hum Pathol 2004;35c290-7.
19. Aitchison AA, Veerakumarasivara A, Vias M, Kumar R, Hamdy FC, Neal DE, Mills 1G. Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer. Prostate 2008;68:661-74.
20. Kim IY, Ahn HJ, Zelner DJ, Shaw J W, Sensibar JA, Kim JH, Kato M, Lee C. Genetic change in transforming growth factor β (TGF-β) re ceptor type I gene correlates with insensitivity to TGF-β 1 in human prostate cancer cells. Cancer Res 1996;56:44-8.
21. Wilding G, Zugraeier G, Knabbe C, Flanders K, Gelmann E. Differential effects of transforming growth factor β on human prostate cancer cells in vitro. Mol Cell Endocrinol 1989;62:79-87.
22. van der Poel HG. Androgen receptor and TGFβ1/Smad signaling are mutually inhibitory in prostate cancer. Eur Urol 2005;48:1051-8
23. Landstrom M, Heldin NE, Bu S, Herraansson A, Itoh S, ten Dijke P, Heldin CH. Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells. Curr Biol 2000; 10:535-8.
24. Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β 1 on programmed cell death through a p53- and TGF-independent mechanism. J Biol Chem 1997:272: 12181-8.
25. Morton DM, Barrack ER. Modulation of transforming growth factor β 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res 1995;55:2596-602.
26. Nairn AC, Bhagat B, Palfrey HC. Identification of calmodulin-de-pendent protein kinase Til and its major Mr 100.000 substrate in mammalian tissues. Proc Natl Acad Sci USA 1985;82:7939-43.
27. Nastiuk KL, Kim JW, Mann M, Krolewski JJ. Androgen regulation of FLICE-like inhibitory protein gene expression in the rat prostate. J Cell Physiol 2003; 196:386-93.
28. Danielpour D, Kadoraatsu K, Anzano MA, Smith JM, Sporn MB. Development and characterization of nontumorigenic and tumorigenie epithelial cell lines from rat dorsal-lateral prostate. Cancer Res 1994:54:3413-21.
29. Nastiuk KL, Yoo K, Lo K, Su K, Yeung P, Kutaka J, Danielpour D, Krolewski JJ. FLICE-like inhibitory protein blocks TGFB I induced caspase activation and apoptosis in prostate epithelial cells. Mol Can Res 2008;8:231-I2.
30. Peehl DM, Wong ST, Stamey TA. Clonal growth characteristics of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 1988;24:530-6.
31. Jakowlew SB, Moody TW, Mariano JM. Transforming growth factor-β receptors in human cancer cell lines: analysis of transcript, protein and proliferation. Anticancer Res 1997;17:1849-60.
32. Song K, Cornelius SC, Reiss M, Danielpour D. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-β by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. J Biol Chem 2003;278: 38342-51.
33. Comforth AN, Davis JS, Khanifar E, Nastiuk KL, Krolewski JJ. FOX03a mediates the androgen-dependent regulation of FLIP and contributes to TRAlL-induced apoptosis of LNCaP cells. Oncogene 2008:27:4422-33.
34. Peter ME. Krammer PH. The CD95(APO-l/Fas) DISC and beyond. Cell Death Differ 2003;10:26-35.
35. Hsing AY, Kadomatsu K, Bonhara MJ, Danielpour D. Regulation of apoptosis induced by transforming growth factor-β 1 in nontumorigenic rat prostatic epithelial cell lines. Cancer Res 1996;56:5146-9.
36. Gao S, Wang H, Lee P, Melaraed J, Li CX, Zhang F, Wu H, Zhou L, Wang Z. Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland. J Mol Endocrinol 2006;36:463-83.
37. Gao S, Lee P, Wang H, Gerald W, Adler M, Zhang L, Wang YF, Wang Z. The androgen receptor directly targets the cellular Fas/FasL-assoeiated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells. Mol Endocrinol 2005; 19:1792-802.
38. Sharp DA, Lawrence DA, Ashkenazi A. Selective knockdown of the long variant of cellular FLTCE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J Biol Chem 2005:280:19401-9.
39. Zhang X, Jin TG, Yang H, DeWolf WC, Khosravi-Far R, Olumi AF. Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer. Cancer Res 2004;64: 7086-91.
40. Rippo MR, Moretti S, Vescovi S, Tomasetti M, Orecehia S, Amici G, Catalano A, Procopio A. FLIP overexpression inhibits death receptor-induced apoptosis in malignant raesothelial cells. Oncogene 2004:23:7753-60.
41. Wang P, Zhang J, Bellail A, Jiang W, Hugh J, Kneteraan NM, Hao C. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Cell Signal 2007;19:2237-46.
42. Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, Walc-zak H. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. Etnbo J 2002; 21:4520-30.
43. Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P, Gazdar A, Blenis J, Arnott D, Ashkenazi A. Death receptor recruit ment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 2001;276:46639-46.
44. Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ. Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 2001:98:13884-8.
45. Day TW, Najafi F, Wu CH, Safa AR. Cellular FLICE-iike inhibitory protein (c-FLTP): a novel target for Taxol-induced apoptosis. Biochem Pharmacol 2006;71:1551-61.
46. Longley DB, Wilson TR, McEwan M, Allen WL, McDermott U, Galligan L, Johnston PG. c-FLIP inhibits chemotherapy-induced colorectal cancer cell death. Oncogene 2006;25:838-48.
47. Wilson TR, McLaughlin KM, McEwan M, Sakai H, Rogers KM, Redmond KM, Johnston PG, Longley DB. c-FLIP: a key regulator of colorectal cancer cell death. Cancer Res 2007:67:5754-62.
48. Debes JD, Tindall DJ. Mechanisms of androgen-refractorv prostate cancer. N Engl J Med 2004;3514488-90.
49. Nastiuk KL, Krolewski JJ. FLIP-ping out-death receptor signaling in the prostate. Cancer Biol Ther 2008;7:1171-9.
50. Nemeth JA, Sensibar JA, White RR, Zelner DJ, Kim IY, Lee C. Prostatic ductal system in rats: tissue-specific expression and regional variation in stromal distribution of transforming growth factor-p 1. Prostate 1997:33:64-71.